Inside informationFrench
Communiqué de presse : Qfitlia et Cablivi de Sanofi approuvés en Chine, élargissant la prise en charge des maladies rares
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 11/12/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- French
- AMF reference
- 134207_20251211